SCIENCE 37

Blogs

SCIENCE 37

Blogs

You Can Work from Home, You Can See a Doctor from Home…and Now You Can Participate in a Clinical Trial from Home

Former U.S. Congressman Gregg Harper’s son, Livingston, has Fragile X Syndrome (FXS), a rare neurological disease often misdiagnosed as autism or attention deficit/hyperactivity…

https://science37dev.prod.acquia-sites.com/you-can-work-home-you-can-see-doctor-homeand-now-you-can-participate-clinical-trial-home

Blog

A Conversation with Freenome and Jonathan Cotliar, M.D., Chief Medical Officer, Science 37

In a few words, what is Science 37 and what is the benefit of decentralized clinical trials? We are a technology-enabled clinical research organization. Our mission is faster…

/Resources/conversation-freenome-and-jonathan-cotliar-md-chief-medical-officer-science-37

Blog

Embracing Virtual in Psychiatry Research

The field of clinical research has undergone a remarkable transformation in recent years, accelerated by the global pandemic. The emergence of decentralized clinical trials (DCT) has…

https://science37.com/embracing-virtual-psychiatry-research

Blog

Rare Disease Research: The Impact of Decentralized Trials

Collectively, rare diseases are not so rare. About 350 million people worldwide and roughly 1 in 10 Americans live with one of the more than 7,000 identified rare diseases. …

https://science37.com/rare-disease-research-impact-decentralized-trials

Blog

How Decentralized Trials Transform Patient Recruitment

In the dynamic landscape of clinical research, the challenge of patient recruitment remains a critical hurdle. As trial criteria become more stringent, locating participants has become…

https://science37.com/how-decentralized-trials-transform-patient-recruitment

Blog

Decentralized Clinical Trials: Why They Matter

In the past few years, the clinical trial industry has witnessed a shift with the inception of decentralized clinical trials (DCT). This approach is more than just the use of eConsent…

Learn More

/decentralized-clinical-trials-why-they-matter

Blog

The Time for Decentralized Clinical Trials is Now

The FDA Draft Guidance on Decentralized Clinical Trials provides recommendations for clinical trial sponsors to incorporate virtual elements into clinical research. Authors: Irena…

Learn More

/new-fda-guidelines-show-time-virtual-clinical-trials-now

Blog

Three Ways the Metasite™ Model Creates Value for Dermatologic Clinical Trials

The past decade has brought an explosion of new therapies for patients with dermatologic disease. With numerous new treatments on the horizon, it is an exciting and hopeful time for…

Learn More

/three-ways-metasite-model-creates-value-dermatologic-clinical-trials

Blog

Treated Like a Human, Not a Statistic

Virtual clinical trial access program provided breast cancer patients with personal, in-home treatment during the COVID-19 pandemic.

Read Now

/treated-human-not-statistic

Blog

Top Five Reasons to Include Virtual Sites in Your Infectious Disease Research

Virtual sites can help deliver infectious disease studies more quickly, more inclusively and in a more patient-centric way.

Read Now

/top-five-reasons-include-virtual-sites-your-infectious-disease-research

Blog

4 Things to Know about the EMA’s Updated Decentralized Clinical Trial Recommendations

Studies with Decentralized Clinical Trial (DCT) elements must be fit-for-purpose—and designed to protect patient safety, privacy and rights

/four-things-know-about-emas-updated-decentralized-clinical-trial-recommendations

Blog

Science 37 Forecast—The Adoption of Hybrid Oncology Trials Will Accelerate in 2023 and Beyond

Oncology is a therapeutic area of singular importance in clinical research. Breakthroughs in drug discovery will catalyze numerous studies for targeted cancer treatments, with Evaluate…

/science-37-forecast-adoption-hybrid-oncology-trials-will-accelerate-2023-and-beyond

Blog

What Clinical Trial Patient Participants Want

A new groundbreaking research study reveals the perceptions and preferences of clinical trial participants and how those determinants impact all factors of the trial lifecycle. In her…

/what-clinical-trial-patient-participants-want

Blog

Pharma Execs Prefer Hybrid Clinical Trials

Hybrid clinical trials continue to gain traction as stakeholders see the measurable benefits that remote study technology brings to clinical research. Read the latest blog from Drew…

/pharma-execs-prefer-hybrid-clinical-trials

Blog

A Long-Time Pharmaceutical Executive’s Experience Participating in a Clinical Trial

With 15 years of experience in pharmaceuticals, Science 37’s Leah Zilla thought she knew what to expect when she signed up for a traditional trial for a COVID-19 vaccine. Her…

Read Now

/long-time-pharmaceutical-executives-experience-participating-clinical-trial

Blog

Decentralized Clinical Trials—Where the Industry is Now

The clear and hidden benefits of the hybrid and decentralized clinical trial models and how to implement agile trials to enhance clinical research.

Read Now

/decentralized-clinical-trials-where-industry-now

Blog

Refining, Rethinking, and Decentralizing Clinical Research

Decentralized tools and technologies will continue to provide new opportunities for patient engagement post-COVID.

Read Now

/refining-rethinking-and-decentralizing-clinical-research

Blog

Using eCOA on a mobile device for a decentralized clinical trial

How Accelerating eCOA Implementation Benefits Decentralized Clinical Trials

A key benefit of decentralized clinical trials is the ability to enable faster trials, through improved patient recruitment, retention, and diversity. eCOA, when implemented correctly…

/how-accelerating-ecoa-implementation-benefits-decentralized-clinical-trials

Blog

Is Your Clinical Trial Technology Disconnected?

How to improve patient, site, and sponsor/CRO experience through unified technology.

Read Now

https://www.science37.com/your-clinical-trial-technology-disconnected

Blog

Cancer Patients Prefer Decentralized Trials

A new industry survey shows oncology trials are embracing decentralized methods to keep patients safe, engaged, and committed.

Read now

/cancer-patients-prefer-decentralized-trials

Blog

Improving the Patient Journey & Increasing Equitable Access in Oncology Research

Accurate representations of patient populations are critical to producing reliable clinical evidence for patient care.

Read now

/improving-patient-journey-increasing-equitable-access-oncology-research

Blog

A New Era of Accessible Clinical Trials

The original clinical trial laid the foundation for modern clinical studies. Thanks to the people working in clinical research, we have the opportunity to provide access to more people…

/new-era-accessible-clinical-trials

Blog

Building Inclusive Clinical Trials for the LGBTQIA+ Community

As we consider the strides made in awareness and visibility through Pride Month, we look at our own arena, healthcare, and see a much different picture.

Read Now

/building-inclusive-clinical-trials-strategies-include-lgbtqia-community

Blog

A New Era of Accessible Clinical Trials

On this Clinical Trials Day, we highlight the opportunity to provide access to more people in more places and thank the people working within clinical research to make it happen.

Read now

/new-era-accessible-clinical-trials

Blog

Investing in our Mobile Nursing Network and Elevating our Nurses Voices

This International Nurses Day we elevate the voices of our mobile nursing team and share what inspires them most about their work in decentralized clinical trials.

Read now

/investing-our-mobile-nursing-network-elevating-our-nurses-voices

Blog

New Diversity Reporting Imperatives For Clinical Trial Sponsors By Lawmakers & Regulators

The F.D.A. recommends that clinical trial sponsors develop a Race and Ethnicity Diversity Plan to inform outreach, recruitment and retention throughout the trial process.

Read now

/new-diversity-reporting-imperatives-clinical-trial-sponsors-lawmakers-regulators

Blog

A New Clinical Leadership—The Agile Clinical Trial

To access the full advantage of decentralized trials, sponsors have to begin the planning process with agile in mind.

Read now

/new-clinical-leadership-agile-clinical-trial

Blog

Enhancing CNS Studies with Agile and Decentralized Clinical Trials

CNS clinical trials are among the fastest-growing adopters of decentralization.

Read now

/enhancing-cns-studies-agile-and-decentralized-clinical-trials

Blog

Can the future of ending health disparities and improving health outcomes for Black Americans be in participation in clinical trials? What role does mental health play in current and future health outcomes? A panel of experts discuss.

Breaking Through Mistrust to Better Mental Health in Black Communities

What role does mental health play in current and future health outcomes? A panel of experts discuss.

Read now

/breaking-through-mistrust-better-mental-health-black-communities

Blog

Powering Rare Disease Research with Agile, Decentralized and Patient-Centric Approaches

Here are key takeaways from a recent Science 37-hosted rare disease-focused webinar:

Read now

/powering-rare-disease-research-agile-decentralized-and-patient-centric-approaches

Blog

learn more about reshaping trials in 2022, click here to download our latest report

Reshaping Clinical Trials in 2022

Read now

/reshaping-clinical-trials-2022

Blog

Privacy By Design Protects Clinical Trial Participants

Happy Data Privacy Day! But, really, isn’t every day privacy day? As Science 37’s Privacy Officer, I certainly take that approach. Protecting the privacy rights and…

Read now

/privacy-design-protects-clinical-trial-participants

Blog

How Access to the HPV Vaccination is Helping to Eliminate Cervical Cancer

With the arrival of Cervical Health Awareness Month, comes news out of the U.K. that The human papillomavirus, or HPV, the vaccine is cutting cases of cervical cancer by nearly 90%.

Read now

/how-access-hpv-vaccination-helping-eliminate-cervical-cancer

Blog

Working with Native Americans to Navigate the COVID-19 Crisis

This Native American Heritage Month, we take a look at how the COVID-19 crisis has highlighted long standing inequities, as well as the fight to overcome them.

Read now

/Resources/Working-with-Native-Americans-to-Navigate